$6.94
0.182.66%
At Close: -
$6.96
0.020.29%
After Hours: Aug 23, 6:30 PM EDT
15 minutes delayed
Comments
Loading...
Altimmune (NASDAQ:ALT) Stock, Earnings Estimates, EPS, And Revenue
Altimmune reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 5
EPS Estimate
$-0.370
Quarterly Revenue Estimate
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$409K
Analyze the earnings history of Altimmune using advanced sorting and filters.
Data brought to you by Benzinga APIs
Altimmune (ALT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-08 | $-0.35 | $-0.34 | -2.94 % |
| Mar 2024 | 2024-05-09 | $-0.34 | $-0.37 | 8.11 % |
| Dec 2023 | 2024-03-27 | $-0.33 | $-0.43 | 23.3 % |
| Sep 2023 | 2023-11-07 | $-0.39 | $-0.42 | 7.14 % |
Altimmune (ALT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2022 | 2023-02-28 | $-110.00K | $30.00K | -466.7 % |
| Sep 2022 | 2022-11-10 | $2.00K | $870.00K | -99.8 % |
| Jun 2022 | 2022-08-11 | $8.00K | $870.00K | -99.1 % |
| Mar 2022 | 2022-05-12 | $32.00K | $1.03M | -96.9 % |
FAQ
When is Altimmune (NASDAQ:ALT) reporting earnings?
Altimmune (ALT) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
What were the latest earnings per share (EPS) for Altimmune (NASDAQ:ALT)?
The Actual EPS was $-0.35, which missed the estimate of $-0.34.
What were Altimmune’s (NASDAQ:ALT) revenues?
The Actual Revenue was $5K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.